FDA Approved: GLEOLAN — Supplemental Application (Medexus Pharma, Inc.)

View source ↗

Summary

The FDA has approved a supplemental application for Gleolan (aminolevulinic acid hydrochloride) filed by Medexus Pharma, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Glioma
• High-grade Glioma

Drugs mentioned

• Gleolan (5-aminolevulinic acid hydrochloride)

Snippet

SUPPL AP for GLEOLAN (AMINOLEVULINIC ACID HYDROCHLORIDE)